HANGZHOU, ZHEJIANG, CHINA, October 9, 2026 /EINPresswire.com/ -- Developing a custom valve closure requires aligning ...
Zacks Investment Research on MSN
4 semiconductor stocks to grab as sales hit $1 trillion for first time
Semiconductor stocks have been the market’s darling over the past few years. Enthusiasm surrounding artificial intelligence (AI), especially generative AI, has been providing a major boost to chip ...
Researchers have developed a self-powered angular displacement sensor that combines triboelectric nanogenerator technology ...
Organic light-emitting diodes have long faced an awkward trade-off: the optical tricks that make displays bright and ...
Tarcocimab, tabirafusp-ted were noninferior to aflibercept in DAYBREAK wet AMD trial; 54% on tarcocimab reached 24-week dosing.
D-150 is advancing into Phase 3 development for DME, a second multi-billion-dollar retinal disease market with significant unmet need First patients have been enrolled in 4SIGHT global Phase 3 trial ...
QRDC validates QuantLase’s Photonic Intelligence Processing Unit (PIPU) research, building on the initial whitepaper ...
The first patients have been enrolled in 4SIGHT, a global phase 3 trial comparing a single intravitreal injection of the investigational gene therapy 4D-150 with aflibercept 2 mg ...
Operatingefficiency has improved markedly, and the quality of profitability has strengthened significantly. The company ...
D Molecular Therapeutics announced that the first patients have been enrolled across multiple sites in the 4SIGHT Phase 3 clinical trial evaluating 4D-150 for the treatment of diabetic macular edema ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results